On December 20, 2016, the U.S. Patent and Trademark Office (USPTO) issued Patent Number PP27,475 (Cannabis Plant Named ‘Ecuadorian Sativa’) to the Company’s wholly owned subsidiary. Management believes the patented plant may prevent some cancers and may cause apoptosis of cancer cells in vivo. Attached to this filing as Exhibit 99 is a copy of a press release that more fully discusses possible medical benefits of the patented plant.

ITEM 9.01 Exhibits.

Attached to this filing as Exhibit 99 is a copy of the press release announcing the granting of Patent No. PP27,475.

PAGE

About Cannabis Sativa, Inc. (OTCMKTS:CBDS)